Tech Company Financing Transactions
Femasys Funding Round
Femasys closed a $40 million Series C investment round on 12/17/2016. Investors included Salem Partners and private investors.
Transaction Overview
Company Name
Announced On
12/17/2016
Transaction Type
Venture Equity
Amount
$40,000,000
Round
Series C
Investors
Proceeds Purpose
The funding will be used primarily to support the pivotal testing of FemBloc, the Company's revolutionary, non-surgical permanent contraception solution.
Company Information
Company Status
Publicly-held
Industry
Medical Devices & Instruments
Mailing Address
3950 Johns Creek Ct. 100
Suwanee, GA 30024
USA
Suwanee, GA 30024
USA
Phone
Website
Email Address
Overview
Femasys is engaged in R&D and manufacture of medical devices for women's healthcare.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Kathy Lee-Sepsick
Chief Financial Officer
Todd Creech
Chief Medical Officer
Jeffrey Marcus
VP - Bus. Development
Steven Damon
VP - Finance
Gary Thompson
VP - Manufacturing
Timothy Pruitt
VP - Operations
Daniel Currie
Browse more venture capital transactions:
Prev: 12/17/2016: Intrinsic Therapeutics venture capital transaction
Next: 12/17/2016: LeanKit venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC transactions on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs